LifeStance Health Group, Inc. (NASDAQ:LFST – Get Free Report) has earned a consensus rating of “Moderate Buy” from the eleven ratings firms that are presently covering the firm, Marketbeat.com reports. Four equities research analysts have rated the stock with a hold rating, six have assigned a buy rating and one has issued a strong buy rating on the company. The average 1-year target price among brokers that have issued ratings on the stock in the last year is $13.12.
LFST has been the topic of a number of research analyst reports. Weiss Ratings raised shares of LifeStance Health Group from a “hold (c-)” rating to a “hold (c)” rating in a research note on Tuesday, August 11th. Wall Street Zen lowered shares of LifeStance Health Group from a “strong-buy” rating to a “buy” rating in a report on Saturday, September 5th. Zacks Research lowered shares of LifeStance Health Group from a “strong-buy” rating to a “hold” rating in a report on Monday, July 13th. KeyCorp increased their price objective on shares of LifeStance Health Group from $13.00 to $15.00 and gave the stock an “overweight” rating in a research report on Monday, October 5th. Finally, Barclays lifted their target price on shares of LifeStance Health Group from $13.00 to $15.00 and gave the company an “overweight” rating in a report on Thursday, September 10th.
Read Our Latest Report on LifeStance Health Group
LifeStance Health Group Price Performance
LifeStance Health Group (NASDAQ:LFST – Get Free Report) last posted its earnings results on Thursday, August 6th. The company reported $0.06 EPS for the quarter, beating analysts’ consensus estimates of $0.03 by $0.03. The company had revenue of $435.35 million for the quarter, compared to analysts’ expectations of $414.58 million. LifeStance Health Group had a net margin of 3.19% and a return on equity of 3.39%. LifeStance Health Group’s revenue for the quarter was up 26.1% compared to the same quarter last year. During the same quarter in the prior year, the company posted ($0.01) earnings per share. On average, sell-side analysts forecast that LifeStance Health Group will post 0.16 earnings per share for the current year.
Insider Buying and Selling at LifeStance Health Group
In other news, CTO Vukasin Paunovich sold 42,067 shares of the firm’s stock in a transaction on Wednesday, September 2nd. The stock was sold at an average price of $12.87, for a total transaction of $541,402.29. Following the completion of the transaction, the chief technology officer directly owned 205,379 shares in the company, valued at $2,643,227.73. This trade represents a 17.00% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, major shareholder Tpg Gp A, Llc sold 13,643,207 shares of the firm’s stock in a transaction on Monday, August 10th. The stock was sold at an average price of $10.62, for a total value of $144,890,858.34. Following the transaction, the insider owned 98,101,407 shares of the company’s stock, valued at approximately $1,041,836,942.34. This represents a 12.21% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 13,777,580 shares of company stock valued at $146,433,781 over the last quarter. 3.50% of the stock is owned by company insiders.
Institutional Investors Weigh In On LifeStance Health Group
Institutional investors and hedge funds have recently modified their holdings of the company. Everhart Financial Group Inc. lifted its stake in LifeStance Health Group by 1.3% during the 3rd quarter. Everhart Financial Group Inc. now owns 112,844 shares of the company’s stock worth $1,358,000 after acquiring an additional 1,435 shares in the last quarter. WINTON GROUP Ltd grew its position in LifeStance Health Group by 522.3% in the 2nd quarter. WINTON GROUP Ltd now owns 186,589 shares of the company’s stock valued at $1,998,000 after acquiring an additional 156,607 shares in the last quarter. Engineers Gate Manager LP acquired a new position in LifeStance Health Group in the 2nd quarter valued at about $166,000. Integrated Wealth Concepts LLC acquired a new position in LifeStance Health Group in the 2nd quarter valued at about $91,000. Finally, IFP Advisors Inc increased its stake in LifeStance Health Group by 316.5% during the second quarter. IFP Advisors Inc now owns 3,694 shares of the company’s stock worth $40,000 after purchasing an additional 2,807 shares during the period. Hedge funds and other institutional investors own 85.50% of the company’s stock.
LifeStance Health Group Company Profile
LifeStance Health Group, Inc is a U.S.-based healthcare company that provides outpatient mental health services through a network of clinicians. Its services are delivered through both in-person appointments and a virtual care platform, allowing patients to access care in a range of settings.
The company offers psychiatric evaluation and treatment, psychotherapy, medication management, psychological and neuropsychological testing, and related behavioral health services. LifeStance serves children, adolescents, and adults, addressing conditions such as anxiety, depression, attention-deficit/hyperactivity disorder, and other mental health and behavioral concerns.
LifeStance operates across multiple states in the United States and combines company-operated clinics with telehealth services.
Featured Stories
- Five stocks we like better than LifeStance Health Group
- 3 Stocks Chopped in Half: Why These Drops May Be Structural, Not a Dip
- Home Depot and Lowe’s Hit 52-Week Lows—But Analysts Aren’t Giving Up
- Utilities Are Bouncing Back—These 2 Giants Could Signal the Next Big Sector Rally
- Q3 Earnings Could Blow Past Consensus—Be Ready for What Comes Next
Receive News & Ratings for LifeStance Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeStance Health Group and related companies with MarketBeat.com's FREE daily email newsletter.
